Home › Non-Small Cell Lung Cancer › Wisconsin › La Crosse
Non-Small Cell Lung Cancer clinical trials in La Crosse, WI
10 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around La Crosse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Gundersen Lutheran Medical Center, La Crosse
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Gundersen Lutheran Medical Center, La Crosse
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RecruitingPhase 2
- Gundersen Lutheran Medical Center, La Crosse
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RecruitingPhase 2/3
- Gundersen Lutheran Medical Center, La Crosse
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Gundersen Lutheran Medical Center, La Crosse
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Gundersen Lutheran Medical Center, La Crosse
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Gundersen Lutheran Medical Center, La Crosse
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Gundersen Lutheran Medical Center, La Crosse
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Gundersen Lutheran Medical Center, La Crosse
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
GEMINI-NSCLC: NSCLC Biomarker Study
RecruitingObservational study
- Gundersen Health System, La Crosse
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in La Crosse
- Lung Cancer9 studies
- Acute Myeloid Leukemia6 studies
- Breast Cancer6 studies
- Multiple Myeloma4 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Laryngeal Cancer3 studies
- Oral Cancer3 studies
- Melanoma3 studies
- Endometrial Cancer3 studies
- Ovarian Cancer3 studies
- Diffuse Large B-Cell Lymphoma3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.